Xarelto Lawsuits

Published By:
Picture of Jessica Paluch-Hoerman
Jessica Paluch-Hoerman

Attorney Jessica Paluch-Hoerman, founder of TruLaw, has over 28 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Xarelto Lawsuits Overview

TruLaw is not currently taking new Xarelto clients.

Xarelto lawsuits are currently being filed on behalf of individuals that experienced uncontrollable bleeding events.

Xarelto and other drugs like Pradaxa and Eliquis are blood thinners designed to prevent strokes and blood clots.

Table of Contents

Xarelto, Pradaxa, and Eliquis Linked to Uncontrollable Bleeding

In recent years, new oral anticoagulants such as Xarelto, Eliquis and Pradaxa have taken over a lot of the market formerly owned by warfarin, because of their “convenience.”

Marketed as requiring less effort in blood tests and managing food interactions, these new anticoagulants also carry a risk that was not present in warfarin – no antidote to stop uncontrolled bleeding.

Many times the ability to reverse the effects of Xarelto, Eliquis or Pradaxa can be a matter of life or death.

According to the Institute of Safe Medicines Practices (ISMP), a watchdog group, anticoagulant drugs are a “high-risk treatment” and cause bleeding in approximately 15% of patients with atrial fibrillation.

Many physicians are wary of the new anticoagulants, since there is limited evidence on how to manage bleeding in patients taking them since there is no known reversal of the anticoagulant effect.

New anticoagulants such as Xarelto, Eliquis and Pradaxa have been linked to an increased number of uncontrollable blood injuries because there was no approved antidote for patients who use the medication.

Pradaxa Lawsuit Settlement

In May 2014, nearly 4,000 individuals harmed by uncontrollable bleeding with the drug Pradaxa received $650 million in compensation for their injuries.

More Pradaxa Lawsuits are moving forward today for individuals who were harmed prior to the FDA approval of a Praxbind in October 2015.

Xarelto Lawsuits Move Forward

Xarelto is at the center of numerous lawsuits claiming personal injury and wrongful death.

Plaintiffs allegedly suffered uncontrollable bleeding which resulted in severe injuries and deaths caused by Xarelto.

Xarelto lawsuits accuse the manufactures of failing to adequately warn consumers and doctors of the side effects that can occur with an uncontrollable bleed and hiding important safety information which resulted in over a hundred deaths and over thousands of fatal injuries.

Almost 20,000 Xarelto lawsuits have been centralized in federal multidistrict litigation (MDL) in U.S. District Court, Eastern District of Louisiana, where Judge Eldon Fallon selected four bellwether cases that resulted in defense verdicts.

A fourth bellwether trial is set to begin on December 2.

On the other hand, a jury in Philadelphia, swiftly found Bayer to be at fault for the gastrointestinal bleeding of Lynn Hartman, the first trial to go forward in Pennsylvania state court.

In December 2017, the jury awarded Xarelto plaintiff Lynn Hartman $28 million – with $26 million of them assigned as punitive damages designed to send a message to Bayer.

This case was later thrown out by a state judge after hearing arguments that the plaintiff’s doctor testified that additional warnings would not have changed her decision to prescribe the drug.

There are than 1,500 cases remaining in state court in Pennsylvania and more cases filed in state court cases in Pennsylvania, Delaware, and California.

The first Xarelto bleeding lawsuits were filed against Bayer Healthcare Pharmaceuticals, Inc. and Johnson & Johnson (and its subsidiary Janssen Pharmaceuticals, Inc.) in early 2014.

This and other Xarelto lawsuits claim that the drug makers were negligent in promoting Xarelto as a safe and effective alternative to warfarin that do not require the same kind of stringent monitoring required of warfarin.

But many experts believe that monitoring is actually more important for Xarelto should catastrophic bleeding events occur, since the drug has no approved reversal agent.

In October 2015, the FDA approved Praxbind, a reversal agent specifically created for Pradaxa.

Xarelto Lawsuits are currently moving forward in the Eastern District of Louisinana presided by the Honorable Kurt D. Engelhardt with the first Bellwether trials set to move forward in February 2017.

Xarelto / Pradaxa Injuries & Side Effects

Most Serious Complications

The most serious complications with Xarelto and Pradaxa include, but are not limited to, the follow ten (10) conditions:

  • Gastrointestinal bleeding
  • Stroke
  • Rectal bleeding
  • Heart Attack
  • Hernia Recurrence
  • Pulmonary Embolism
  • Adhesion (Scar-like tissue that sticks tissues together)
  • Epidural
  • Hematoma
  • Internal bleeding
  • Brain Hemorrhage

Anticoagulant Drugs With No Reversal Agent Still On The Market

The risk of bleeding is a problem with all blood thinners, however, with warfarin, doctors can turn to an “antidote” of Vitamin K to stop the bleeding.

Xarelto and Eliquis do not currently have an antidote to stop a severe, life-threatning bleed.

However, five years after approval, in October 2015, an antidote for Pradaxa, Praxbind, was finally FDA approved.

Frequently Asked Questions

Published By:
Picture of Jessica Paluch-Hoerman
Jessica Paluch-Hoerman

Managing Attorney & Owner

With over 25 years of legal experience, Jessica Paluch-Hoerman is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share the most reliable, accurate, and up-to-date legal information with our readers!

AFFF Lawsuit

AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.

Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.

Depo Provera Lawsuit

Depo Provera Lawsuit claims are being filed by individuals who allege they developed meningioma (a type of brain tumor) after receiving Depo-Provera birth control injections.

A 2024 study found that women using Depo-Provera for at least 1 year are five times more likely to develop meningioma brain tumors compared to those not using the drug.

Suboxone Lawsuit

Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.

Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.

Social Media Lawsuits

Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.

Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.

Vaginal Mesh Lawsuits

Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.

Bair Hugger Lawsuit

Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).

Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.

Baby Formula NEC Lawsuit

Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.

Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Recent Articles

All
FAQs
Injuries & Conditions
Legal Help
Military
Other Resources
Settlements & Compensation